Research and development expenses were $21.8 million for the quarter ended December 31, 2024, compared to $11.6 million for the same period in 2023. The increase of $10.2 million was primarily driven ...
Silent rhinovirus (RV) infection is prevalent in nasal tissues and is associated with distinct immune responses in those with and without chronic rhinosinusitis with nasal polyps (CRSwNP). These were ...
The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...
Chronic sinusitis with nasal polyps (CRSwNP) accounts for 20 to 33 percent of these cases. Even after surgical treatment, the ...
A proposed stop gap funding deal to keep the federal government operating includes $1.06 billion in anomalies to cover the ...
Phase 1 healthy volunteer trial ongoing, complete SAD/MAD data expected in June 2025KT-621 Phase 1b trial in atopic dermatitis ...
Rich Catalyst Calendar Expected in 2025 Including Phase 2 Data in Multiple Immuno-InflammatoryDisease Indications -- Data from CTTQ’s Phase 2 ...
These risks and uncertainties are described in greater detail in the section entitled “Risk Factors” in the most recent Annual Report on Form 10-K and in subsequent filings with the SEC.
Data from CTTQ's Phase 2 Studies of Bosakitug (ATI-045) in Chinese Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Expected in the ... results for the fourth quarter ...
Short on space or budget? A full-size bed is a smart pick. CNET's sleep experts tested dozens to find the best options for every type of sleeper.
Commissions do not affect our editors' opinions or evaluations. Full coverage car insurance is a must if you want insurance that’ll pay out if you harm others with your vehicle or your vehicle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results